Screener
NovoCure NVCR Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | June 30,2026 | December 31, 2025 |
|---|---|---|
| LONG-TERM ASSETS: | ||
| Property and equipment, net | 75,369 | 77,606 |
| Field equipment, net | 26,582 | 22,066 |
| Right-of-use assets | 43,789 | 47,327 |
| Other long-term assets | 10,930 | 10,596 |
| Total long-term assets | 156,670 | 157,595 |
| TOTAL ASSETS | $795,191 | $804,326 |
| The accompanying notes are an integral part of these unaudited consolidated financial statements. |
Item 1. Financial Statements
FAQ
- What is NovoCure's total assets?
- NovoCure (NVCR) reported total assets of $795.19M in Q2 2026.
- How has NovoCure's total assets changed year-over-year?
- NovoCure's total assets decreased by 36.2% year-over-year, from $1.25B to $795.19M.
- What is the long-term trend for NovoCure's total assets?
- Over 5 years (2020 to 2025), NovoCure's total assets has grown at a -5.2% compound annual growth rate (CAGR), from $1.05B to $804.33M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about NovoCure's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude